medwireNews: Blood-based biomarkers are a useful tool for stratifying an individual’s risk for Alzheimer’s disease (AD) in the early stages of cognitive decline, but do they actually “diagnose” AD in the truest sense?
26-03-2024 | Alzheimer's Disease | News